Mark VanRaden
Impact in
- Virology top 2%
- HIV Research and Treatment
- Hepatology top 2%
- Hepatitis C virus research
Papers in
-
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 and COVID-19 Research 2
- Viral Infections and Outbreaks Research 2
-
- HIV, Drug Use, Sexual Risk 3
- Co-authors
- Richard A. Kaslow (6 shared papers)Lawrence Kingsley (6 shared papers)Roger Detels (3 shared papers)John Phair (3 shared papers)Harvey J. Alter (2 shared papers)Jacqueline C. Melpolder (2 shared papers)Cathy Conry‐Cantilena (2 shared papers)Joan Gibble (1 shared paper)
- Journals
- Vaccine (2 papers)The Lancet (2 papers)New England Journal of Medicine (2 papers)Transfusion (1 paper)Infection and Immunity (1 paper)
- Partner nations
- United StatesVietnamSpain
In The Last Decade
Mark VanRaden
20 papers receiving 1.9k citations
Mark VanRaden's Hit Papers
Peers
Comparison fields: 5 of 111
- Virology 294
- Hepatology 451
- Parasitology 368
- Infectious Diseases 839
- Epidemiology 682
Countries citing papers authored by Mark VanRaden
This map shows the geographic impact of Mark VanRaden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark VanRaden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark VanRaden more than expected).
Fields of papers citing papers by Mark VanRaden
This network shows the impact of papers produced by Mark VanRaden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark VanRaden. The network helps show where Mark VanRaden may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark VanRaden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Routes of Infection, Viremia, and Liver Disease in Blood Donors Found to Have Hepatitis C Virus Infection Hit paper breakdown → | 1996 | 536 |
| 2 | 2006 | 281 | |
| 3 | 1987 | 269 | |
| 4 | 1989 | 185 | |
| 5 | 1990 | 180 | |
| 6 | 2007 | 101 | |
| 7 | 1990 | 96 | |
| 8 | 1990 | 86 | |
| 9 | 1991 | 70 | |
| 10 | 2014 | 61 | |
| 11 | 1990 | 37 | |
| 12 | 2018 | 16 | |
| 13 | 2013 | 14 | |
| 14 | 2016 | 11 | |
| 15 | 2016 | 11 | |
| 16 | 2017 | 8 | |
| 17 | 1993 | 8 | |
| 18 | 1995 | 6 | |
| 19 | 2006 | 2 | |
| 20 | Estimation of pertussis vaccine efficacy in the presence of covariates in three randomized trials. | 1997 | 1 |
About Mark VanRaden
Mark VanRaden is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Virology and Critical Care and Intensive Care Medicine, having authored 20 papers that have together received 2.0k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (4 papers), HIV Research and Treatment (3 papers), HIV, Drug Use, Sexual Risk (3 papers), Vector-borne infectious diseases (2 papers), Hepatitis C virus research (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Viral Infections and Outbreaks Research (2 papers) and Thermal Regulation in Medicine (2 papers). The work is most often cited by research in Virology (294 citations), Hepatology (451 citations), Parasitology (368 citations), Infectious Diseases (839 citations) and Epidemiology (682 citations). Mark VanRaden has collaborated with scholars based in United States, Vietnam and Spain. Frequent co-authors include Richard A. Kaslow, Lawrence Kingsley, Roger Detels, John Phair, Harvey J. Alter, Jacqueline C. Melpolder, Cathy Conry‐Cantilena, Joan Gibble, Paul M. Ness and Jay H. Hoofnagle. Their work appears in journals such as Vaccine, The Lancet, New England Journal of Medicine, Transfusion and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.